Table of Content

"1    INTRODUCTION    33
1.1    STUDY OBJECTIVES    33
1.2    MARKET DEFINITION    33
1.2.1    INCLUSIONS AND EXCLUSIONS    33
1.3    MARKET SCOPE    34
1.3.1    MARKET SEGMENTATION    34
1.3.2    GEOGRAPHIC SCOPE    34
1.3.3    YEARS CONSIDERED    35
1.4    CURRENCY    35
1.5    LIMITATIONS    35
1.6    STAKEHOLDERS    36
1.7    SUMMARY OF CHANGES    36
2    RESEARCH METHODOLOGY    38
2.1    RESEARCH DATA    38
FIGURE 1    RESEARCH DESIGN    38
2.1.1    SECONDARY DATA    39
2.1.1.1    Key data from secondary sources    40
2.1.2    PRIMARY DATA    40
FIGURE 2    PRIMARY SOURCES    40
2.1.2.1    Key data from primary sources    41
2.1.2.2    Key industry insights    42
FIGURE 3    BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS    42
FIGURE 4    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION    43
2.2    MARKET SIZE ESTIMATION    43
FIGURE 5    REVENUE SHARE ANALYSIS ILLUSTRATION: BELIMED AG
(A METALL ZUG GROUP COMPANY).    44
FIGURE 6    MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
 (SUPPLY SIDE): COLLECTIVE REVENUE OF ENDOSCOPE REPROCESSING PRODUCTS AND SERVICES    44
FIGURE 7    CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS    45
FIGURE 8    TOP-DOWN APPROACH    46
2.3    MARKET BREAKDOWN AND DATA TRIANGULATION    47
FIGURE 9    DATA TRIANGULATION METHODOLOGY    47
2.4    STUDY ASSUMPTIONS    48
2.5    RISK ASSESSMENT/FACTOR ANALYSIS    48
TABLE 1    RISKS    48

3    EXECUTIVE SUMMARY    49
FIGURE 10    ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2022 VS. 2027 (USD BILLION)    49
FIGURE 11    ENDOSCOPE REPROCESSING MARKET, BY END-USER,
2022 VS. 2027 (USD BILLION)    50
FIGURE 12    ENDOSCOPE REPROCESSING MARKET, BY REGION,
2022 VS. 2027 (USD BILLION)    51
4    PREMIUM INSIGHTS    52
4.1    ENDOSCOPE REPROCESSING MARKET OVERVIEW    52
FIGURE 13    RISING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES TO DRIVE MARKET GROWTH    52
4.2    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2021)    53
FIGURE 14    HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT TO DOMINATE MARKET IN 2021    53
4.3    GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET    54
FIGURE 15    CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD    54
5    MARKET OVERVIEW    55
5.1    INTRODUCTION    55
5.2    MARKET DYNAMICS    55
FIGURE 16    ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    55
5.2.1    DRIVERS    56
5.2.1.1    Increasing requirement for endoscopy to diagnose
and treat target diseases    56
5.2.1.2    High risk of endoscope-associated infections    56
5.2.1.3    Growing geriatric population and subsequent increase
in endoscopic procedures    57
5.2.1.4    Increasing emphasis on improving reprocessing guidelines
by healthcare authorities    58
5.2.1.5    Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy    59
TABLE 2    MAJOR DEVELOPMENTS    59
5.2.1.6    Increasing preference for minimally invasive surgeries    59
5.2.1.7    Rising focus of medical specialists and healthcare providers on shifting from manual to automated endoscopy reprocessing    60
5.2.2    RESTRAINTS    61
5.2.2.1    Concerns related to reprocessed instrument safety    61
5.2.2.2    Adverse effects of chemical disinfectants    61
5.2.2.3    High overhead costs of endoscopy procedures with limited reimbursement in developing countries    62
5.2.2.4    High risk of COVID-19 transmission during endoscopic procedures    62

5.2.3    OPPORTUNITIES    63
5.2.3.1    Growing medical devices industry in emerging economies    63
FIGURE 17    MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION)    64
5.2.4    CHALLENGES    64
5.2.4.1    Preference for single-use endoscopes    64
5.2.4.2    Increasing number of product failures and recalls    65
5.2.4.3    Shortage of trained professionals    65
5.2.4.4    Lack of awareness associated with reprocessing methods    66
5.2.4.5    Increasing FDA recommended measures to
reduce infection transmission    66
5.3    COVID-19 IMPACT ANALYSIS    67
FIGURE 18    PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK
BEFORE AND DURING COVID-19    67
5.4    RANGES/ SCENARIOS    68
5.4.1    ENDOSCOPE REPROCESSING MARKET    68
FIGURE 19    REALISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET    68
FIGURE 20    PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET    69
FIGURE 21    OPTIMISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET    69
5.5    REGULATORY ANALYSIS    70
TABLE 3    INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
MEDICAL DEVICE REPROCESSING    70
5.5.1    NORTH AMERICA    70
5.5.1.1    US    70
FIGURE 22    PREMARKET NOTIFICATION: 510(K) APPROVAL FOR
REPROCESSED MEDICAL DEVICES    71
5.5.1.2    Canada    71
TABLE 4    CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES    72
5.5.2    EUROPE    73
FIGURE 23    CE MARKING FOR REPROCESSED MEDICAL DEVICES    73
5.5.2.1    Germany    73
5.5.2.2    Rest of Europe    74
5.5.3    ASIA PACIFIC    74
5.5.3.1    Japan    74
5.5.3.2    Australia    74
5.5.3.3    Rest of Asia Pacific    74
5.5.4    LATIN AMERICA    75
5.5.5    MIDDLE EAST & AFRICA    75
5.6    PORTER’S FIVE FORCES ANALYSIS    75
5.6.1    THREAT FROM NEW ENTRANTS    76
5.6.2    BARGAINING POWER OF SUPPLIERS    76
5.6.3    BARGAINING POWER OF BUYERS    76
5.6.4    INTENSITY OF COMPETITIVE RIVALRY    76
5.6.5    THREAT FROM SUBSTITUTES    77
5.7    SUPPLY CHAIN ANALYSIS    77
FIGURE 24    DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES    78
5.8    VALUE CHAIN ANALYSIS    78
FIGURE 25    VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED
DURING MANUFACTURING AND ASSEMBLY PHASES    78
5.9    ECOSYSTEM ANALYSIS    79
FIGURE 26    ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS    79
5.9.1    ROLE IN ECOSYSTEM    80
FIGURE 27    KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET ECOSYSTEM    80
5.10    TECHNOLOGY ANALYSIS    81
5.11    KEY CONFERENCES & EVENTS IN 2022-2023    82
TABLE 5    ENDOSCOPE REPROCESSING MARKET: DETAILED LIST
OF CONFERENCES & EVENTS    82
5.12    PATENT ANALYSIS    83
5.12.1    PATENT GRANTED TRENDS FOR ENDOSCOPE REPROCESSORS    84
FIGURE 28    PATENT GRANTED TRENDS OF AUTOMATED ENDOSCOPE REPROCESSORS, JANUARY 2011– APRIL 2022    84
FIGURE 29    PATENT GRANTED TRENDS OF HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011– FEBRUARY 2022    85
FIGURE 30    PATENT GRANTED TRENDS OF ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011– APRIL 2022    85
5.12.2    JURISDICTION AND TOP APPLICANT ANALYSIS    86
FIGURE 31    TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AUTOMATED ENDOSCOPE REPROCESSORS PATENTS,
JANUARY 2011—APRIL 2022    86
FIGURE 32    TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011—APRIL 2022    87
FIGURE 33    TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011— APRIL 2022    88
5.13    TRADE ANALYSIS    88
5.13.1    IMPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION)    89
5.13.2    EXPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION)    89
5.13.3    EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021    90
5.13.4    IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021    90
5.14    PRICING ANALYSIS    91
TABLE 6    AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT    91
TABLE 7    AVERAGE SELLING PRICE FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY    91
TABLE 8    COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER    92
TABLE 9    TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE    93
5.15    KEY STAKEHOLDERS & BUYING CRITERIA    93
5.15.1    KEY STAKEHOLDERS IN BUYING PROCESS    93
FIGURE 34    INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS    93
TABLE 10    INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS (%)    94
5.15.2    BUYING CRITERIA    94
FIGURE 35    KEY BUYING CRITERIA FOR END USERS    94
TABLE 11    KEY BUYING CRITERIA FOR END USERS    95
5.16    TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES    95
5.16.1    REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS    95
FIGURE 36    REVENUE SHIFT FOR ENDOSCOPE REPROCESSING    96
6    ENDOSCOPE REPROCESSING MARKET, BY PRODUCT    97
6.1    INTRODUCTION    98
TABLE 12    ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    98
TABLE 13    ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    99
6.2    HIGH-LEVEL DISINFECTANTS AND TEST STRIPS    99
6.2.1    OUTBREAK OF INFECTIOUS DISEASES TO DRIVE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS DEMAND    99
TABLE 14    ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017–2020 (USD MILLION)    100
TABLE 15    ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2021–2027 (USD MILLION)    100
6.3    DETERGENTS & WIPES    101
6.3.1    INCREASING EMPHASIS ON PRE-CLEANING METHODS
TO PROPEL SEGMENT GROWTH    101
TABLE 16    ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES,
BY REGION, 2017–2020 (USD MILLION)    101
TABLE 17    ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES,
BY REGION, 2021–2027 (USD MILLION)    102
6.4    AUTOMATED ENDOSCOPE REPROCESSORS    102
6.4.1    INCREASED EFFICIENCY OF AUTOMATED ENDOSCOPE REPROCESSORS OVER MANUAL CLEANING TO DRIVE MARKET GROWTH    102
TABLE 18    MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS    103
TABLE 19    ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2017–2020 (USD MILLION)    104
TABLE 20    ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2021–2027 (USD MILLION)    104
6.4.2    AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY    105
6.4.2.1    Introduction    105
TABLE 21    ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2017–2020 (USD MILLION)    105
TABLE 22    ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2021–2027 (USD MILLION)    105
6.4.2.2    Standalone AER    105
TABLE 23    ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017–2020 (USD MILLION)    106
TABLE 24    ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2021–2027 (USD MILLION)    106
6.4.2.3    Portable AER    106
TABLE 25    ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2017–2020 (USD MILLION)    107
TABLE 26    ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2021–2027 (USD MILLION)    107
6.4.3    AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE    107
TABLE 27    ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2017–2020 (USD MILLION)    108
TABLE 28    ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2021–2027 (USD MILLION)    108
6.4.3.1    Single-basin AER    108
TABLE 29    MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (SINGLE BASIN)    108
6.4.3.2    Double-basin AER    109
TABLE 30    MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (DUAL BASIN)    109
6.5    ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS    109
6.5.1    GUIDELINES FOR DRYING, STORAGE, AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO DRIVE MARKET GROWTH    109
TABLE 31    ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED    110
TABLE 32    ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017–2020 (USD MILLION)    111
TABLE 33    ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2021–2027 (USD MILLION)    111
6.6    ENDOSCOPE TRACKING SYSTEMS    112
6.6.1    RISING FOCUS ON REPROCESSING TO DRIVE SEGMENT GROWTH    112
TABLE 34    ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2017–2020 (USD MILLION)    113
TABLE 35    ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2021–2027 (USD MILLION)    113
6.7    OTHER PRODUCTS    114
TABLE 36    OTHER PRODUCTS OFFERED BY MANUFACTURERS    115
TABLE 37    ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2017–2020 (USD MILLION)    116
TABLE 38    ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2021–2027 (USD MILLION)    116
7    ENDOSCOPE REPROCESSING MARKET, BY END USER    117
7.1    INTRODUCTION    118
TABLE 39    ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    118
TABLE 40    ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    118
7.2    HOSPITALS    119
7.2.1    LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS    119
TABLE 41    ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2017–2020 (USD MILLION)    120
TABLE 42    ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2021–2027 (USD MILLION)    120
7.3    AMBULATORY SURGERY CENTERS AND CLINICS    121
7.3.1    COST-EFFECTIVENESS OF AMBULATORY SURGERY CENTERS AND CLINICS TO DRIVE MARKET GROWTH    121
TABLE 43    NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY
CENTERS IN US, 2013–2017    121
TABLE 44    TOTAL AMBULATORY SURGERY CENTER PROCEDURES IN US, 2015–2021    122
TABLE 45    ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2017–2020 (USD MILLION)    123
TABLE 46    ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2021–2027 (USD MILLION)    123
7.4    OTHER END USERS    124
TABLE 47    ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2017–2020 (USD MILLION)    124
TABLE 48    ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2021–2027 (USD MILLION)    125
8    ENDOSCOPE REPROCESSING MARKET, BY REGION    126
8.1    INTRODUCTION    127
TABLE 49    ENDOSCOPE REPROCESSING MARKET, BY REGION,
2017–2020 (USD MILLION)    127
TABLE 50    ENDOSCOPE REPROCESSING MARKET, BY REGION,
2021–2027 (USD MILLION)    127
8.2    NORTH AMERICA    128
FIGURE 37    NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT    128
TABLE 51    NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)    129
TABLE 52    NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION)    129
TABLE 53    NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)    130
TABLE 54    NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)    130
TABLE 55    NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    131
TABLE 56    NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    131
TABLE 57    NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)    131
TABLE 58    NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)    132
8.2.1    US    132
8.2.1.1    Favorable reimbursement scenario to propel market growth    132
TABLE 59    MEDICARE NATIONAL AVERAGE COVERAGE FOR
OUTPATIENT PROCEDURES, 2021    132
TABLE 60    US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    134
TABLE 61    US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    134
TABLE 62    US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    135
TABLE 63    US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    135
TABLE 64    US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    135
TABLE 65    US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    136
8.2.2    CANADA    136
8.2.2.1    High prevalence of hospital-acquired infections to drive market growth    136
TABLE 66    CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025    137
TABLE 67    CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    137
TABLE 68    CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    138
TABLE 69    CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    138
TABLE 70    CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    139
TABLE 71    CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    139
TABLE 72    CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    139
8.3    EUROPE    140
TABLE 73    EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION)    140
TABLE 74    EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION)    140
TABLE 75    EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    141
TABLE 76    EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    141
TABLE 77    EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    142
TABLE 78    EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    142
TABLE 79    EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    142
TABLE 80    EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    143
8.3.1    GERMANY    143
8.3.1.1    Increased surgical procedures to propel market growth    143
TABLE 81    GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025    144
TABLE 82    GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    144
TABLE 83    GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    145
TABLE 84    GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    145
TABLE 85    GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    146
TABLE 86    GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    146
TABLE 87    GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    146
8.3.2    UK    147
8.3.2.1    Increasing use of endoscopy procedures to drive market growth    147
FIGURE 38    MEAN PERCENTAGE CHANGE IN ENDOSCOPE PROCEDURE NUMBERS BETWEEN 2017 AND 2019    148
TABLE 88    UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    149
TABLE 89    UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    149
TABLE 90    UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    150
TABLE 91    UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    150
TABLE 92    UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    150
TABLE 93    UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    151
8.3.3    FRANCE    151
8.3.3.1    Increasing prevalence of cancer to support market growth    151
TABLE 94    FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025    152
TABLE 95    FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    152
TABLE 96    FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    153
TABLE 97    FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    153
TABLE 98    FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    154
TABLE 99    FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    154
TABLE 100    FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    154
8.3.4    ITALY    155
8.3.4.1    Growing geriatric population to support market growth    155
TABLE 101    ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025    155
TABLE 102    ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    156
TABLE 103    ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    156
TABLE 104    ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    157
TABLE 105    ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    157
TABLE 106    ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    157
TABLE 107    ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    158
8.3.5    SPAIN    158
8.3.5.1    Developing healthcare infrastructure to support market growth    158
TABLE 108    SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    159
TABLE 109    SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    159
TABLE 110    SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    160
TABLE 111    SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    160
TABLE 112    SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    160
TABLE 113    SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    161
8.3.6    REST OF EUROPE    161
TABLE 114    REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)    162
TABLE 115    REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)    162
TABLE 116    REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    163
TABLE 117    REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    163
TABLE 118    REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)    163
TABLE 119    REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)    164
8.4    ASIA PACIFIC    164
FIGURE 39    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT    165
TABLE 120    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION)    166
TABLE 121    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION)    166
TABLE 122    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    167
TABLE 123    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    167
TABLE 124    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    168
TABLE 125    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    168
TABLE 126    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    168
TABLE 127    ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    169
8.4.1    JAPAN    169
8.4.1.1    Increasing use of endoscopes to drive market growth    169
TABLE 128    JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    170
TABLE 129    JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    171
TABLE 130    JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    171
TABLE 131    JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    172
TABLE 132    JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    172
TABLE 133    JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    172
8.4.2    CHINA    173
8.4.2.1    Rising prevalence of cancer to increase endoscopic procedures    173
TABLE 134    CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025    173
TABLE 135    CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
 2017–2020 (USD MILLION)    174
TABLE 136    CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    174
TABLE 137    CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    175
TABLE 138    CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    175
TABLE 139    CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    175
TABLE 140    CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    176
8.4.3    INDIA    176
8.4.3.1    Developing healthcare infrastructure to support market growth    176
TABLE 141    INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025    177
TABLE 142    INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    177
TABLE 143    INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    178
TABLE 144    INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    178
TABLE 145    INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    179
TABLE 146    INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION)    179
TABLE 147    INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION)    179
8.4.4    REST OF ASIA PACIFIC    180
TABLE 148    INCIDENCE OF CANCER IN REST OF ASIA PACIFIC COUNTRIES    180
TABLE 149    REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)    181
TABLE 150    REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)    181
TABLE 151    REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION)    182
TABLE 152    REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION)    182
TABLE 153    REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)    182
TABLE 154    REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)    183
8.5    REST OF THE WORLD    183
TABLE 155    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION)    183
TABLE 156    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021–2027 (USD MILLION)    184
TABLE 157    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)    184
TABLE 158    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)    185
TABLE 159    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION)    185
TABLE 160    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION)    186
TABLE 161    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)    186
TABLE 162    REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)    186
8.5.1    LATIN AMERICA    187
8.5.1.1    Rising prevalence of infections due to endoscopy-related procedures to support market growth    187
TABLE 163    LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025    188
TABLE 164    LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025    188
TABLE 165    BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025    188
TABLE 166    LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION)    189
TABLE 167    LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION)    189
TABLE 168    LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)    190
TABLE 169    LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)    190
TABLE 170    LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)    190
TABLE 171    LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)    191
8.5.2    MIDDLE EAST & AFRICA    191
8.5.2.1    Introduction of regulatory frameworks for medical equipment reprocessing to drive market growth    191
TABLE 172    AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025    192
TABLE 173    MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2017–2020 (USD MILLION)    192
TABLE 174    MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2021–2027 (USD MILLION)    193
TABLE 175    MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION)    193
TABLE 176    MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION)    194
TABLE 177    MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION)    194
TABLE 178    MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION)    194
9    COMPETITIVE LANDSCAPE    195
9.1    OVERVIEW    195
9.2    KEY PLAYER STRATEGIES/RIGHT TO WIN    195
TABLE 179    OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS    195
9.3    REVENUE ANALYSIS    196
FIGURE 40    REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE
 REPROCESSING MARKET    197
9.4    MARKET SHARE ANALYSIS    197
FIGURE 41    ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020    198
TABLE 180    ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION    198
9.5    COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)    200
9.5.1    STARS    200
9.5.2    EMERGING LEADERS    200
9.5.3    PERVASIVE PLAYERS    200
9.5.4    PARTICIPANTS    200
FIGURE 42    VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET    201

9.6    COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)    202
9.6.1    PROGRESSIVE COMPANIES    202
9.6.2    STARTING BLOCKS    202
9.6.3    RESPONSIVE COMPANIES    202
9.6.4    DYNAMIC COMPANIES    202
FIGURE 43    ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020    203
9.6.4.1    COMPETITIVE BENCHMARKING    204
TABLE 181    ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUP/SMES    204
TABLE 182    ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES]    205
9.7    COMPANY FOOTPRINT    206
TABLE 183    COMPANY FOOTPRINT    206
TABLE 184    COMPANY PRODUCT FOOTPRINT    207
TABLE 185    COMPANY GEOGRAPHICAL FOOTPRINT    208
9.8    COMPETITIVE SCENARIO AND TRENDS    209
9.8.1    DEALS    209
TABLE 186    DEALS, JANUARY 2019- APRIL 2022    209
9.8.2    PRODUCT LAUNCHES & APPROVALS    210
TABLE 187    PRODUCT LAUNCHES & APPROVALS, JANUARY 2019- APRIL 2022    210
9.8.3    EXPANSIONS    211
TABLE 188    EXPANSIONS, JANUARY 2019- APRIL 2022    211
10    COMPANY PROFILES    212
10.1    KEY PLAYERS    212
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1    CANTEL MEDICAL    212
TABLE 189    CANTEL MEDICAL: BUSINESS OVERVIEW    212
FIGURE 44    CANTEL MEDICAL: COMPANY SNAPSHOT (2020)    213
10.1.2    ADVANCED STERILIZATION PRODUCTS (FORTIVE)    217
TABLE 190    ADVANCED STERILIZATION PRODUCTS (FORTIVE): BUSINESS OVERVIEW    217
FIGURE 45    ADVANCED STERILIZATION PRODUCTS (FORTIVE):
COMPANY SNAPSHOT (2020)    218
10.1.3    OLYMPUS CORPORATION    221
TABLE 191    OLYMPUS CORPORATION: BUSINESS OVERVIEW    221
FIGURE 46    OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)    222
10.1.4    ECOLAB    225
TABLE 192    ECOLAB: BUSINESS OVERVIEW    225
FIGURE 47    ECOLAB: COMPANY SNAPSHOT (2021)    226
10.1.5    STERIS    229
TABLE 193    STERIS: BUSINESS OVERVIEW    229
FIGURE 48    STERIS: COMPANY SNAPSHOT (2020)    230
10.1.6    GETINGE AB    234
TABLE 194    GETINGE AB: BUSINESS OVERVIEW    234
FIGURE 49    GETINGE AB: COMPANY SNAPSHOT (2021)    235
10.1.7    WASSENBURG MEDICAL (A MEMBER OF HOYA)    239
TABLE 195    WASSENBURG MEDICAL (A MEMBER OF HOYA): BUSINESS OVERVIEW    239
FIGURE 50    WASSENBURG MEDICAL (A MEMBER OF HOYA):
COMPANY SNAPSHOT (2020)    239
10.1.8    CONMED CORPORATION    241
TABLE 196    CONMED CORPORATION: BUSINESS OVERVIEW    241
FIGURE 51    CONMED CORPORATION: COMPANY SNAPSHOT (2021)    242
10.1.9    BELIMED AG (A METALL ZUG GROUP COMPANY)    243
TABLE 197    BELIMED AG (METALL ZUG GROUP COMPANY): BUSINESS OVERVIEW    243
FIGURE 52    BELIMED AG (METALL ZUG GROUP COMPANY): COMPANY SNAPSHOT (2021)    244
10.1.10    ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL)    246
TABLE 198    ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): BUSINESS OVERVIEW    246
FIGURE 53    ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL):
COMPANY SNAPSHOT (2020)    246
10.1.11    CUSTOM ULTRASONICS    249
TABLE 199    CUSTOM ULTRASONICS: BUSINESS OVERVIEW    249
10.1.12    STEELCO S.P.A    250
TABLE 200    STEELCO S.P.A: BUSINESS OVERVIEW    250
10.1.13    BES HEALTHCARE (A DIVISION OF BES REHAB LTD)    252
TABLE 201    BES HEALTHCARE: BUSINESS OVERVIEW    252
10.1.14    ARC HEALTHCARE SOLUTIONS    253
TABLE 202    ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW    253
10.1.15    METREX RESEARCH, LLC    254
TABLE 203    METREX RESEARCH. LLC: BUSINESS OVERVIEW    254
10.2    OTHER PLAYERS    255
10.2.1    RICHARD WOLF GMBH    255
TABLE 204    RICHARD WOLF GMBH: BUSINESS OVERVIEW    255
10.2.2    MEDALKAN    255
TABLE 205    MEDALKAN: BUSINESS OVERVIEW    255
10.2.3    MICRO-SCIENTIFIC, LLC    256
TABLE 206    MICRO-SCIENTIFIC, LLC: BUSINESS OVERVIEW    256
10.2.4    BORER CHEMIE AG    256
TABLE 207    BORER CHEMIE AG: BUSINESS OVERVIEW    256
10.2.5    MEDONICA CO. LTD    257
TABLE 208    MEDONICA CO. LTD: BUSINESS OVERVIEW    257
10.2.6    TUTTNAUER    257
TABLE 209    TUTTNAUER: BUSINESS OVERVIEW    257
10.2.7    ATMS    258
TABLE 210    ATMS: BUSINESS OVERVIEW    258
10.2.8    SUMMIT IMAGING, INC.    258
TABLE 211    SUMMIT IMAGING, INC.: BUSINESS OVERVIEW    258
10.2.9    SHINVA MEDICAL INSTRUMENT CO., LTD    259
TABLE 212    SHINVA MEDICAL INSTRUMENT CO., LTD: BUSINESS OVERVIEW    259
10.2.10    MEDICAL DEVICES GROUP SRL    259
TABLE 213    MEDICAL DEVICES GROUP SRL: BUSINESS OVERVIEW    259
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11    APPENDIX    260
11.1    DISCUSSION GUIDE    260
11.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    264
11.3    AVAILABLE CUSTOMIZATIONS    266
11.4    RELATED REPORTS    266
11.5    AUTHOR DETAILS    267"